TABLE 1.
Sequence (5′→3′) | Application |
---|---|
GAGGAATACAGGGTACCATGAGTGATAAAACAAAAAACACAAAAC; GGTTTGTCC TCCTGCAGGGTTGTGCATTATTCCAGGAAG | Construct for His6-tagged SigA |
AAAAGCAGGTGGGGTACCATGCCAAAAGTATCTCAACC; TTTGATTCAACTGCAGT GTTCATTTACTCC | Construct for His6-tagged SigB |
AAGTGGGGAATTCTGTATTTATTATGTC; TTTGGCGCTGCAGAAGCATCGATCTC | pUC18*PrsbV, template for in vitro transcription |
GTATTGTGGATCCAACTAAAGTAACACG; CCATCACTGCAGCAATACCAATAAGTG | pUC18*Pbsh, template for in vitro transcription |
AAGGATTGGTACCTTTTCCGACTTATC; ATAATCACTGCAGTCCCCGCTAATAA | pUC18*Plmo0596, template for in vitro transcription |
AATCCGTTTCTAGATATGTATGC; ATACAATAAGCTTGTGGATCCCA | pUC18*PprfA, template for in vitro transcription |
CAACAAATATGTCTATGTGGTC | Primer extension of PrsbV |
CGGCGTAACAACCACAACTTC | Primer extension of Pbsh |
CCGCTAATAAAACAAGAATTCGTG | Primer extension of Plmo0596 |
GGTTTTATCCCGTTAG | Primer extension of PprfA |
Primers were used for His6-tagged SigA and SigB constructs and cloning of in vitro transcription templates. Oligonucleotides were used for primer extension. Restriction sites that were used are underlined.